New hope for multiple sclerosis patients
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
In what might come as a relief for many patients who suffer from disability due to multiple sclerosis, clinical trials for a medicine to treat this disease has been approved.

The move is despite stringent regulations recently introduced by the Drug Controller General of India which had halted clinical trials in the country for a while. PGIMER is one of seven such institutes in India which has been selected for the trials to be conducted in 32 countries.

The drug `ofatumumab' for which the trial will start soon is expected to offer lesser side effects and will be more effective than the existing drug `teriflunomide' in patients who suffer from relapsing multiple sclerosis. In India, some 9-10 in every 1 lakh persons suffer from the disease. It is believed that there are over 1 lakh patients in the country.

http://timesofindia.indiatimes.com/city/chandigarh/new-hope-for-multiple-sclerosis-patients/articleshow/58971055.cms
Preview
Dr. T●●●j S●●●●●i and 8 others like this
Like
Comment
Share